All sites C00-96,D32-33,D42-43,D45-47,D76 449 88.5 3.9 4.0 0.7 2.8
Mouth, pharynx C00-14 6 100.0 - - - -
  Lip C00 0 100.0 - - - -
  Tongue C02 2 100.0 - - - -
  Mouth, other C03-06 2 100.0 - - - -
  Salivary glands C07-08 1 100.0 - - - -
  Pharynx C01,C09-14 1 100.0 - - - -
Digestive organs C15-26 83 74.2 6.7 11.6 1.7 5.8
  Oesophagus C15 3 100.0 - - - -
  Stomach C16 10 96.1 - - 2.0 2.0
  Small intestine C17 1 100.0 - - - -
  Colon C18 24 96.6 - 2.5 0.8 -
  Rectum, rectosigmoid C19-20 15 98.7 - - - 1.3
  Anus C21 0 100.0 - - - -
  Liver C22 5 47.8 13.0 30.4 - 8.7
  Gallbladder, bile ducts C23-24 7 39.4 24.2 15.2 3.0 18.2
  Pancreas C25 17 25.3 18.4 37.9 2.3 16.1
  Other digestive organs C26 1 25.0 25.0 - 50.0 -
Respiratory organs C30-39 21 62.1 20.4 13.6 1.0 2.9
  Nose, sinuses C30-31 0 100.0 - - - -
  Larynx, epiglottis C32 0 100.0 - - - -
  Lung, trachea C33-34 20 61.6 21.2 13.1 1.0 3.0
  Mediastinum, pleura C38 0 - - 100.0 - -
Bone C40-41 1 80.0 - 20.0 - -
Melanoma of the skin C43 15 100.0 - - - -
Skin, non-melanoma C44 27 100.0 - - - -
Mesothelioma C45 1 100.0 - - - -
Autonomic nervous system C47 - - - - - -
Soft tissues C48-49 3 100.0 - - - -
Breast C50 128 99.7 0.2 0.2 - -
Female genital organs C51-58 60 95.0 3.6 - 0.7 0.7
  Cervix uteri C53 5 96.2 - - 3.8 -
  Corpus uteri C54 31 98.0 0.7 - 0.7 0.7
  Uterus, other C55,C58 - - - - - -
  Ovary C56 15 86.8 13.2 - - -
  Other female genital C51-52,C57 9 97.9 - - - 2.1
Urinary organs C64-68 20 96.0 2.0 - 1.0 1.0
  Kidney C64 11 94.3 1.9 - 1.9 1.9
  Bladder and urinary tract2 C65-68 10 97.9 2.1 - - -
Eye C69 1 100.0 - - - -
Brain, central nervous system C70-72,D32-33,D42-43 15 83.8 - 6.8 1.4 8.1
Thyroid gland C73 12 98.3 - - 1.7 -
Other endocrine glands C74-75 1 100.0 - - - -
Illdefined or unknown C76,C80 10 45.1 17.6 29.4 3.9 3.9
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 47 79.1 6.8 2.6 0.4 11.1
  Hodgkin lymphoma C81 3 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 23 99.1 0.9 - - -
  Malignant immunoproliferative diseases C88 - - - - - -
  Myeloma and other plasma cell tumors C90 5 51.9 14.8 22.2 - 11.1
  Leukaemia C91-95 7 50.0 20.6 - 2.9 26.5
  Myelodysplastic syndromes D46 3 15.4 15.4 - - 69.2
  Myeloproliferaitive neoplasms D45,D47 7 79.4 5.9 - - 14.7
Not included above
  Carcinoma in situ of the breast D05 12 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 36 100.0 - - - -
  Borderline tumour of the ovary D39 6 90.6 - - - 9.4
  Basal cell carcinoma of the skin 171 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.